Dukoral Market 2026 expanding with travel vaccine demand

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Dukoral Market Between 2026 And 2030?

The historical growth was influenced by cholera outbreaks occurring in endemic areas, increasing international travel volumes, official vaccination recommendations, the long-standing presence of waterborne diseases, and the expansion of travel health clinics.

Expected expansion during the forecast period is fueled by a surge in international travel, the wider dissemination of cholera due to climate shifts, increased investment in preventive healthcare, innovations in oral vaccine development, and a heightened emphasis on ensuring the health and safety of travelers. Key trends anticipated for this forecast period encompass a broader acceptance of oral vaccines, an increase in travel-related immunizations, a growing emphasis on preventing enteric diseases, a preference for vaccines that don’t require injections, and greater recognition of the dangers posed by cholera and ETEC.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20040&type=smp

What Major Drivers Are Influencing Demand In The Dukoral Market?

The increasing occurrence of cholera cases is expected to propel the expansion of the dukoral market. Cholera, an acute diarrheal illness caused by consuming food or water contaminated with Vibrio cholerae, leads to severe dehydration and can, in extreme instances, be fatal. The proliferation of cholera is intensified by inadequate sanitation, polluted water, and climate change, which together create favorable conditions for outbreaks. Dukoral, an oral cholera vaccine, assists in reducing cholera cases by stimulating immunity against Vibrio cholerae bacteria and its toxin, thereby lowering the risk of infection. For example, in September 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that in 2023, cholera cases rose by 13%, with a significant 71% surge in fatalities compared to 2022, leading to over 4,000 deaths from a preventable and easily treatable disease. As a result, the escalating incidence of cholera cases is projected to drive the growth of the dukoral market.

Which Market Segments Are Examined In The Dukoral Market Study?

The dukoral market covered in this report is segmented –

1) By Indication: Cholera, Traveler’s Diarrhea

2) By Distribution Channel: Pharmacies, Travel Clinics, Healthcare Providers

3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

Which Trends Are Influencing The Dukoral Market?

Leading companies within the dukoral market are prioritizing novel vaccine formulations, particularly affordable oral cholera vaccines, with the goal of boosting effectiveness and streamlining delivery. Low-cost oral cholera vaccines are defined as affordable and easily administered oral vaccines intended to prevent cholera, particularly crucial for improving access and protection in resource-constrained and outbreak-susceptible regions. As an illustration, in April 2023, a collaboration was established between the International Vaccine Institute (IVI), a non-profit international entity based in South Korea, and Sweden’s University of Gothenburg, focusing on the creation of DuoChol, an economical oral cholera vaccine (OCV). The partnership’s objective is to propel the advancement of DuoChol, characterized by its dry formulation containing inactivated bacterial whole cells and cholera toxin B subunit delivered via a capsule. While similar in composition to DUKORAL, DuoChol boasts enhanced thermostability, maintaining effectiveness at elevated temperatures, alongside reduced weight and volume. The initial phase of its clinical trials is scheduled for Sweden, with funding provided by the Wellcome Trust and the Swedish government.

Who Are The Primary Competitors In The Dukoral Market?

Major companies operating in the dukoral market are Valneva SE

Read the full dukoral market report here:

https://www.thebusinessresearchcompany.com/report/dukoral-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Dukoral Market?

Asia-Pacific was the largest region in the dukoral market in 2025. The regions covered in the dukoral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Dukoral Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20040&type=smp

Browse Through More Reports Similar to the Global Dukoral Market 2026, By The Business Research Company

Direct Selling Market Report 2026

https://www.thebusinessresearchcompany.com/report/direct-selling-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Inductor Market Market Report 2026

https://www.thebusinessresearchcompany.com/report/inductor-market-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795